Clinical Trials Logo

Clinical Trial Summary

This is a long-term safety follow-up study of the Phase I/IIa multicenter study of SCM-AGH in subjects with moderate to severe acute pancreatitis. subjects will be followed up for a maximum period of 240 weeks after the first dose of investigational product. Only subjects previously enrolled in protocol SCM-APT2001 (ClinicalTrials.gov ID: NCT04189419) will be eligible for this long-term follow-up protocol.


Clinical Trial Description

Subjects who meet all eligibility criteria for Long Term Follow-Up(LTFU) study participation at the SCM-APT2001 End of Treatment(EOT) visit may continue LTFU for a maximum period of up to 240 weeks post first dose of investigational product. No additional dosing will be administered on this LTFU protocol. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05955235
Study type Observational
Source SCM Lifescience Co., LTD.
Contact
Status Active, not recruiting
Phase
Start date May 10, 2019
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT03609944 - SpHincterotomy for Acute Recurrent Pancreatitis N/A
Recruiting NCT05572788 - Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts N/A
Completed NCT03642769 - Lactated Ringer's Versus Normal Saline for Acute Pancreatitis N/A
Active, not recruiting NCT05095831 - EUS Shear Wave for Solid Pancreatic Lesions.
Completed NCT04570852 - Acute Pancreatitis Targets (APT) Study N/A
Recruiting NCT03686618 - Secretin for Acute Pancreatitis Phase 2
Not yet recruiting NCT03740685 - Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
Not yet recruiting NCT04037449 - Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis N/A
Completed NCT03342716 - Resolution of Organ Injury in Acute Pancreatitis - RESORP
Not yet recruiting NCT03342807 - Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis Phase 4
Not yet recruiting NCT04760847 - Intermittent Fasting for Pancreatitis N/A
Terminated NCT02959112 - Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography N/A
Recruiting NCT05381428 - Prophylaxis of Post-ERCP Acute Pancreatitis Phase 3
Recruiting NCT05160506 - Corticosteroids to Treat Pancreatitis Phase 2
Not yet recruiting NCT03082469 - Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal Phase 4
Completed NCT03672422 - Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Completed NCT00490386 - Helicobacter Pylori and Acute Alcohol Induced Pancreatitis N/A
Completed NCT04188990 - Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition N/A
Active, not recruiting NCT04743323 - A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease Progression in Acute Pancreatitis
Completed NCT03829085 - Study of the Diet in Patients With the Diagnostic of Acute Pancreatitis N/A